Skip to main content
. 2021 Aug 23;13(16):4229. doi: 10.3390/cancers13164229

Figure 2.

Figure 2

Bone sarcoma stem cells overview. (a) osteosarcoma; (b) Ewing sarcoma; (c) chondrosarcoma. (d) A broad spectrum of CSC markers (black) and the molecular mechanisms underlying CSC phenotypes (blue) have been documented for each sarcoma. Several anti-CSC compounds (red) have been preclinically tried to inhibit CSC phenotypes. Reprinted from an open-access source [20].